BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33760988)

  • 21. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
    Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
    BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
    Rizzolo P; Zelli V; Silvestri V; Valentini V; Zanna I; Bianchi S; Masala G; Spinelli AM; Tibiletti MG; Russo A; Varesco L; Giannini G; Capalbo C; Calistri D; Cortesi L; Viel A; Bonanni B; Azzollini J; Manoukian S; Montagna M; Peterlongo P; Radice P; Palli D; Ottini L
    Int J Cancer; 2019 Jul; 145(2):390-400. PubMed ID: 30613976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.
    Laitman Y; Herskovitz L; Golan T; Kaufman B; Paluch SS; Friedman E
    Fam Cancer; 2012 Jun; 11(2):243-7. PubMed ID: 22219001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome.
    Kim J; Braun D; Ukaegbu C; Dhingra TG; Kastrinos F; Parmigiani G; Syngal S; Yurgelun MB
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):830-837.e1. PubMed ID: 31319185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of
    Rizzolo P; Silvestri V; Bucalo A; Zelli V; Valentini V; Catucci I; Zanna I; Masala G; Bianchi S; Spinelli AM; Tommasi S; Tibiletti MG; Russo A; Varesco L; Coppa A; Calistri D; Cortesi L; Viel A; Bonanni B; Azzollini J; Manoukian S; Montagna M; Radice P; Palli D; Peterlongo P; Ottini L
    Front Oncol; 2018; 8():583. PubMed ID: 30564557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prevalence of Pathogenic or Likely Pathogenic Germline Variants in a Nationwide Cohort of Young Colorectal Cancer Patients Using a Panel of 18 Genes Associated with Colorectal Cancer.
    Frostberg E; Petersen AH; Bojesen A; Rahr HB; Lindebjerg J; Rønlund K
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract.
    Dhooge M; Baert-Desurmont S; Corsini C; Caron O; Andrieu N; Berthet P; Bonadona V; Cohen-Haguenauer O; De Pauw A; Delnatte C; Dussart S; Lasset C; Leroux D; Maugard C; Moretta-Serra J; Popovici C; Buecher B; Colas C; Noguès C;
    Eur J Med Genet; 2020 Dec; 63(12):104080. PubMed ID: 33039684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary diffuse gastric cancer.
    Schrader K; Huntsman D
    Cancer Treat Res; 2010; 155():33-63. PubMed ID: 20517687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial aggregation of gastric cancer].
    Sugimura H
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):551-6. PubMed ID: 18408421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of Pathogenic Germline Variants in
    Petridis C; Arora I; Shah V; Moss CL; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1162-1168. PubMed ID: 31263054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer.
    Donner I; Kiviluoto T; Ristimäki A; Aaltonen LA; Vahteristo P
    Fam Cancer; 2015 Jun; 14(2):241-6. PubMed ID: 25576241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
    Scott CM; Joo JE; O'Callaghan N; Buchanan DD; Clendenning M; Giles GG; Hopper JL; Wong EM; Southey MC
    PLoS One; 2016; 11(11):e0165436. PubMed ID: 27902704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
    Moretta J; Berthet P; Bonadona V; Caron O; Cohen-Haguenauer O; Colas C; Corsini C; Cusin V; De Pauw A; Delnatte C; Dussart S; Jamain C; Longy M; Luporsi E; Maugard C; Nguyen TD; Pujol P; Vaur D; Andrieu N; Lasset C; Noguès C;
    Bull Cancer; 2018 Oct; 105(10):907-917. PubMed ID: 30268633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
    Gylling A; Abdel-Rahman WM; Juhola M; Nuorva K; Hautala E; Järvinen HJ; Mecklin JP; Aarnio M; Peltomäki P
    Gut; 2007 Jul; 56(7):926-33. PubMed ID: 17267619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
    Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
    J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and cancer risk in families with pathogenic
    Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
    J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.